Works by Engebretson, Eric

Results: 3
    1

    DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial.

    Published in:
    Multiple Sclerosis Journal, 2025, v. 31, n. 2, p. 159, doi. 10.1177/13524585241303489
    By:
    • Corboy, John R;
    • Fox, Robert J;
    • Cutter, Gary;
    • Engebretson, Eric;
    • Miller, Aaron;
    • Morgan, Charity;
    • Gustafson, Tarah;
    • Goodman, Andrew D;
    • Kannan, Meena;
    • Sriram, Subramanian;
    • Xia, Zongqi;
    • Lynch, Sharon;
    • Bowen, James;
    • Kister, Ilya
    Publication type:
    Article
    2

    Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis.

    Published in:
    Annals of Clinical & Translational Neurology, 2023, v. 10, n. 4, p. 579, doi. 10.1002/acn3.51745
    By:
    • Barrera, Britney;
    • Simpson, Haley;
    • Engebretson, Eric;
    • Sillau, Stefan;
    • Valdez, Brooke;
    • Parra‐González, José;
    • Winger, Ryan C.;
    • Epperson, Lou Anne;
    • Banks, Ashley;
    • Pierce, Kathryn;
    • Spotts, Melanie;
    • O'Gean, Katie;
    • Alvarez, Enrique;
    • Gross, Robert;
    • Piquet, Amanda L.;
    • Schreiner, Teri;
    • Corboy, John R.;
    • Pei, Jinglan;
    • Vollmer, Timothy L.;
    • Nair, Kavita V.
    Publication type:
    Article
    3